...
首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Sulindac sulfide and caffeic acid phenethyl ester suppress the motility of lung adenocarcinoma cells promoted by transforming growth factor-beta through Akt inhibition.
【24h】

Sulindac sulfide and caffeic acid phenethyl ester suppress the motility of lung adenocarcinoma cells promoted by transforming growth factor-beta through Akt inhibition.

机译:舒林酸硫化物和咖啡酸苯乙酯抑制了肺腺癌细胞的运动,该运动是通过抑制Akt转化生长因子-β促进的。

获取原文
获取原文并翻译 | 示例

摘要

Cell migration is essential for invasive and metastatic phenotypes of cancer cells. Potential chemopreventive agents of cancer-sulindac sulfide, caffeic acid phenethyl ester (CAPE), curcumin, and (+)-catechin-have been reported to interfere with several types of intracellular signaling. In this study, we examined the effects of these agents on transforming growth factor-beta(TGF-beta)-induced motility and Akt phosphorylation in A549 cells. Judged by gold particle phagokinesis assay, sulindac sulfide, CAPE, and curcumin suppressed the motility of A549 cells promoted by TGF-beta. LY294002, a specific inhibitor of phosphatidylinositol 3-kinase(PI3K)/Akt signaling, also suppressed TGF-beta-induced motility and Akt phosphorylation. Sulindac sulfide and CAPE, but not curcumin, suppressed TGF-beta-induced Akt phosphorylation. We conclude that sulindac sulfide and CAPE suppress the motility promoted by TGF-beta in lung adenocarcinoma cells through the suppression of Akt. Our observations raise the possibility that these agents, except for (+)-catechin, can be applied not only as chemopreventive agents but also as anti-metastatic therapy.
机译:细胞迁移对于癌细胞的侵袭和转移表型至关重要。据报道,潜在的癌症化学预防药-舒林酸硫化物,咖啡酸苯乙酯(CAPE),姜黄素和(+)-儿茶素会干扰几种类型的细胞内信号传导。在这项研究中,我们检查了这些试剂对A549细胞中转化生长因子-β(TGF-β)诱导的运动性和Akt磷酸化的影响。通过金颗粒吞噬试验确定,硫化舒林酸,CAPE和姜黄素抑制了TGF-β促进的A549细胞的运动。 LY294002,磷脂酰肌醇3-激酶(PI3K)/ Akt信号转导的特异性抑制剂,也抑制了TGF-β诱导的运动性和Akt磷酸化。舒林酸硫化物和CAPE而非姜黄素可抑制TGF-β诱导的Akt磷酸化。我们得出的结论是,舒林酸硫化物和CAPE通过抑制Akt抑制了肺腺癌细胞中TGF-β促进的运动。我们的观察结果提出了这样的可能性:除(+)-儿茶素外,这些药物不仅可以用作化学预防剂,而且还可以用作抗转移疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号